Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease. Therefore, more reliable biomarkers are required to better predict the prognosis of DLBCL. Cuproptosis is a novel identified form of programmed cell death (PCD) that is different from oxidative stress-related cell death (e.g.,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bingxin, Zhang, Tianyu, Zheng, Ziwei, Lin, Zhili, Wang, Quanqiang, Zheng, Dong, Chen, Zixing, Ma, Yongyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877310/
https://www.ncbi.nlm.nih.gov/pubmed/36713586
http://dx.doi.org/10.3389/fonc.2022.1020566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877310/
https://www.ncbi.nlm.nih.gov/pubmed/36713586
http://dx.doi.org/10.3389/fonc.2022.1020566

Ejemplares similares